Skip to content

Drug interactions

Lapatinib + Memantine-donepezil

Severity: Moderate

Lapatinib and Memantine-donepezil: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lapatinib can prolong the QT interval and donepezil has QT-prolonging potential, so combined use may increase arrhythmia risk. Lapatinib also inhibits CYP3A4 and may modestly raise donepezil levels.

What this interaction means in plain words

Lapatinib and Memantine-donepezil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lapatinib belongs to Oncology; Memantine-donepezil belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive QT prolongation, with possible CYP3A4 inhibition by lapatinib.

What to do

Obtain a baseline ECG and correct electrolytes before starting. Monitor the QTc during treatment.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lapatinib and Memantine-donepezil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lapatinib with Memantine-donepezil?

MediHelp rates the interaction as moderate. Lapatinib and Memantine-donepezil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lapatinib can prolong the QT interval and donepezil has QT-prolonging potential, so combined use may increase arrhythmia risk. Lapatinib also inhibits CYP3A4 and may modestly raise donepezil levels.

How serious is the interaction between Lapatinib and Memantine-donepezil?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and correct electrolytes before starting. Monitor the QTc during treatment.

What other medicines interact with Memantine-donepezil?

MediHelp also lists interactions of Memantine-donepezil with, for example, Dronedarone, Thioridazine, Amantadine. The full list is on the Memantine-donepezil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in